FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

FDA approves NASH liver disease drug from Madrigal Pharmaceuticals

In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen.  Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on Thursday approved the first-ever treatment for a common and potentially deadly form of liver disease that affects millions worldwide. The FDA’s decision means Madrigal Pharmaceuticals … Read more

What’s next in Medicare drug price negotiations

What’s next in Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! The bitter legal battle … Read more

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon Pharmacy will help send certain prescription drugs, including the red-hot weight loss treatment Zepbound, to patients’ homes through the drugmaker’s new direct-to-consumer program.  Starting Wednesday, … Read more

Pfizer is betting big on cancer drugs after Covid decline

Pfizer is betting big on cancer drugs after Covid decline

Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid.  Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. It just might take a while before that bet pays off.  Pfizer pitched its … Read more

Weight loss pill could become a best-in-class drug

Weight loss pill could become a best-in-class drug

Novo Nordisk CEO Lars Fruergaard Jørgensen on Friday said the company’s experimental weight loss pill, amycretin, could eventually become a best-in-class treatment for obesity.  The Danish drugmaker is racing to capitalize on the runaway success of its blockbuster weight loss drug Wegovy by developing a new generation of treatments for obesity, including more convenient and … Read more

Eli Lilly Alzheimer’s drug FDA approval delayed

Eli Lilly Alzheimer’s drug FDA approval delayed

Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early US trading after its experimental drug for Alzheimer’s slowed the progress of the disease in a final-stage trial, paving the way for the company to apply for US approval. AJ Mast | Bloomberg | Getty … Read more

Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

Novo Nordisk market cap surpasses Tesla on new obesity pill trial data

The logo of Danish pharmaceutical company is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February 1, 2017. Liselotte Sabroe | AFP | Getty Images Wegovy obesity drug maker Novo Nordisk surpassed Tesla in market value Thursday, after fresh early trial data showed positive results for its new experimental weight loss pill. … Read more

Cigna to cap employer insurance plan spending

Cigna to cap employer insurance plan spending

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Cigna on Thursday unveiled a new effort to expand insurance coverage for weight loss drugs by limiting how much health plans and employers spend on the highly popular treatments each year.  … Read more

Novo Nordisk shares jump 7% on promising weight loss trial results; Eli Lilly dips

Novo Nordisk shares jump 7% on promising weight loss trial results; Eli Lilly dips

Jonathan Raa | Nurphoto | Getty Images Novo Nordisk shares climbed 7% on Thursday, hitting a fresh record high after the Danish pharmaceutical giant reported positive early trial data for a new experimental weight loss drug. The company told an investor meeting that the Phase I trial of its highly-anticipated obesity drug amycretin showed a … Read more

Medicare should negotiate prices for 50 drugs each year

Medicare should negotiate prices for 50 drugs each year

US President Joe Biden speaks during an event at the National Institutes of Health (NIH) in Bethesda, Maryland, US, on Thursday, Dec. 14 2023.  Chris Kleponis | Bloomberg | Getty Images President Joe Biden on Wednesday said the federal Medicare program should negotiate prices for at least 50 prescription drugs each year, up from the … Read more